Study on the Role of Dihuang Yinzi in Regulating the AMPK/SIRT1/PGC-1α Pathway to Promote Mitochondrial Biogenesis and Improve Alzheimer's Disease

Dihuang Yinzi (DHYZ) is a classic prescription in traditional Chinese medicine. Its therapeutic effect on Alzheimer's disease (AD) has been widely validated. However, the underlying molecular mechanisms of DHYZ in AD treatment remain unclear and require further research.